Company Investors Technology Careers Updates Events Contact Our company mission Positive, passionate and determined to achieve excellence Respectful, with honest communication Accountable to each other Working together to be creative and adventurous Inspiring and celebrating talent wherever we find it 1 Focused on Science We are focused on Science to execute our plans to deliver eye drops for the treatment of retinal vascular diseases including wet AMD and diabetic macular oedema (DME). 2 Collaboration Exonate promotes collaboration and values integrity, respect and accountability. All successes are shared together. 3 Advanced Innovation Advances innovation through industry-leading expertise, continual improvement, creative problem solving and focus on excellence. At Exonate, we want to profoundly improve the lives of those suffering from vision loss. We believe that we have the potential to deliver eye drops to treat diseases such as wet AMD and DME which will not only offer improved quality of life for patients, but also at a much lower administrative cost. Catherine Beech, Exonate’s CEO Why work with us? At Exonate, we offer competitive compensation, equity and comprehensive benefits in addition to other perks to support our team. Diversity We are proud to have a diverse group of employees. We are an Equal Employment Opportunity Employer. Rest and Recharge We encourage our employees to take their paid time off earned to relax and recharge. Learning and Development At Exonate, we promote and support employee learning and development through knowledge sharing, seminars, and training sessions. Our talent development approach helps you drive your career development while your manager coaches. We provide you with the tools and resources needed for your continued professional growth and development. Community and Workspace We work in an environment that fosters collaboration and teamwork. Find your future job Help us revolutionise the treatment of retinal vascular disease APPLY NOW Who we are Exonate is a biopharmaceutical company focused on the discovery and development of small molecule drugs that modulate alternative mRNA splicing to address diseases of high unmet medical need. Alternative mRNA splicing is modulated in disease states resulting in pathological blood vessel formation (angiogenesis) This is a key driver of disease progression in some ophthalmic conditions and cancers. Follow us on Social Media Useful links Career opportunities Technology Investors Contact Copyright © 2021 Exonate Privacy policy Designed and built by Onespacemedia